BeiGene (NasdaqGS:ONC) has climbed 32% over the past quarter, against a backdrop of significant industry challenges and broad market declines. The company's positive momentum can be attributed to the ...
For over four decades, the medical device industry has wrestled with fragmented data exchange and proprietary integrations.
ImmunityBio, Inc.'s advances with Anktiva & rBCG show promise amid financial hurdles. Click here to find out why IBRX stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback